Carter, R. F. Do You Believe That N-of-1 Trials (a Clinical Trial in Which a Single Patient Is the Entire trial), Are Appropriate to Evaluate the Effectiveness of Genomic Therapies for Rare and or Common Genetic Disorders? Do Gene-Editing Targeting Therapies Have the Potential to Expedite the Advancement of Personalized Medicine?. HSI 2017, 8, Page 60-Page 61.